EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion

Weihua Zhang iD, Rongyu Lan, Tingting Shen, Jie Qin, Zhihui Wang, Jiayang Chen, Jiaxing Wang, Zhuotan Wu, Yudong Xu, Yangyang Shen, Qikai Lin, Yuan Chen und 11 weitere

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Weihua Zhang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Spinal Cord, Transplantation, Homologous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Spinal cord injuries (SCI) pose persistent challenges in clinical practice due to the secondary injury. Drawing from our experience in spinal cord fusion (SCF), we propose vascularized allogeneic spinal cord transplantation (vASCT) as a novel approach for SCI, much like organ transplantation has revolutionized organ failure treatment and vascularized composite‐tissue allotransplantation has addressed limb defects. Materials and Methods In this study, 24 dogs were paired and underwent vASCT, with donor spinal cord grafts and polyethylene glycol (PEG) application for SCF. The experimental group ( n = 8) received tacrolimus and methylprednisolone, while the control group ( n = 4) received only methylprednisolone. Safety and efficacy of vASCT were evaluated through electrophysiology, imaging, and 6‐month follow‐up.

Results

The experimental group showed substantial recovery in hind limb motor function. Imaging revealed robust survival of spinal cord grafts and restoration of spinal cord continuity. In contrast, the control group maintained hind limb paralysis, with imaging confirming spinal cord graft necrosis and extensive defects. Electrophysiologically, the experimental group exhibited restored motor evoked potential signal conduction postoperatively, unlike the control group. Notably, PEG application during vASCT led to signal conduction recovery in intraoperative spinal cord evoked potential examinations for all dogs.

Conclusion

In the vASCT surgical model, the combination of PEG with tacrolimus has demonstrated the ability to reconstruct spinal cord continuity and restore hind limb motor function in beagles. Notably, a low dose of tacrolimus has also exhibited an excellent anti‐immune rejection effect. These findings highlight vASCT's potential promise as a therapeutic strategy for addressing irreversible SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesSpinal CordTransplantation, HomologousAnimalsDogsSpinal FusionEvoked Potentials, MotorMaleTacrolimusFemaleRecovery of FunctionImmunosuppressive AgentsMethylprednisolone

Stichwörter der Autor:innen

polyethylene glycolspinal cord defectspinal cord fusionspinal cord injurytacrolimusvascularized allogeneic spinal cord transplantation

Substanzen

TacrolimusImmunosuppressive AgentsMethylprednisolone

Autor:innen und Institutionen

  • Department of Orthopedics, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Institute of Orthopedics, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Global Initiative to Cure Paralysis (GICUP Alliance), Columbus, Ohio, USA.
  • Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Department of Medicine School, Guangxi University, Nanning, Guangxi, China.
  • Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Weihua Zhang, Xiaoping Ren

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Guangxi Zhuang Autonomous Region

Zitieren

APA

Zhang, W., Lan, R., Shen, T., Qin, J., Wang, Z., Chen, J., Wang, J., Wu, Z., Xu, Y., Shen, Y., Lin, Q., Chen, Y., Wei, Y., Liu, Y., Ning, Y., Zhou, Y., Deng, L., Han, L., Wu, X., …, & Ren, X. (2024). A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70020

Vancouver

Zhang W, Lan R, Shen T, Qin J, Wang Z, Chen J, et al. A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70020

BibTeX
@article{Zhang2024,
  author = {Zhang, Weihua and Lan, Rongyu and Shen, Tingting and Qin, Jie and Wang, Zhihui and Chen, Jiayang and Wang, Jiaxing and Wu, Zhuotan and Xu, Yudong and Shen, Yangyang and Lin, Qikai and Chen, Yuan and Wei, Yi and Liu, Yiwen and Ning, Yuance and Zhou, Yiyan and Deng, Liji and Han, Linxuan and Wu, Xiaofei and Deng, Haixuan and Cao, Zhenbin and Yao, Xianping and Ren, Xiaoping},
  title = {A novel strategy for spinal cord reconstruction via vascularized allogeneic spinal cord transplantation combine spinal cord fusion},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70020}
}
Kostenlos starten →